Literature DB >> 17701011

Hepatic lesion of invasive thymoma: possibility of direct invasion.

Tatsuro Okamoto1, Takao Teruya, Kenichi Nishiyama, Riichiroh Maruyama, Fumihiro Shoji, Hiroshi Wataya, Yukito Ichinose.   

Abstract

Thymomas grow slowly but tend to invade the surrounding tissue. We herein report four patients with hepatic lesions of thymomas, which were thought to have directly invaded the liver. These patients had received combined modality treatments throughout the clinical course, and the hepatic lesions appeared a long time after the initial treatment - 11.8 years on average. In these patients, the prognoses after the appearance of hepatic invasion were poor. Appropriate local control in the early stages of the clinical course may therefore be essential for preventing the extrathoracic spread of invasive thymoma.

Entities:  

Mesh:

Year:  2007        PMID: 17701011     DOI: 10.1007/s10147-006-0649-3

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  4 in total

1.  Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis.

Authors:  Philipp Ströbel; Andrea Bauer; Bernhard Puppe; Til Kraushaar; Axel Krein; Klaus Toyka; Ralf Gold; Michael Semik; Reinhard Kiefer; Wilfred Nix; Berthold Schalke; Hans Konrad Müller-Hermelink; Alexander Marx
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

2.  Lymphogenous and hematogenous metastasis of thymic epithelial tumors.

Authors:  Kazuya Kondo; Yasumasa Monden
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

3.  Treatment of invasive thymoma with pleural dissemination.

Authors:  Y Ichinose; M Ohta; T Yano; H Yokoyama; H Asoh; K Hata
Journal:  J Surg Oncol       Date:  1993-11       Impact factor: 3.454

4.  Surgical resection of a solitary liver metastasis in a 46-year-old patient with a malignant thymoma.

Authors:  W J Marasco; C A Hergreuter; E Pritchard; C J O'Hara; G D Steele
Journal:  J Surg Oncol       Date:  1991-02       Impact factor: 3.454

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.